Skip to main content
. 2023 Mar 10;20(6):4880. doi: 10.3390/ijerph20064880

Table 2.

Cannabinoids/metabolites detected in maternal and child urine samples.

Cannabinoid/
Metabolite
Brief Description Cannabinoid Detected in Maternal Urine Cannabinoids Detected in Child Urine
LOQ
ng/mL
n (%) Mean
± SD
Min Max LOD
ng/mL
n (%) Mean
± SD
Min Max
Δ9-THC Most abundant cannabinoid 0.2 3 (4%) 0.3 ± 0.1 0.3 0.4 0.4 0 - - -
11OH-Δ9-THC Primary metabolite of Δ9-THC 0.8 0 1.6 0 - - -
Δ9-THC-COOH Secondary metabolite of Δ9-THC 0.4 4 (5%) 6.0 ± 7.8 0.7 17.6 0.8 0 - - -
Δ9-THC-C-gluc Glucuronidated Δ9-THC-COOH 3.9 6 (7%) 330 ± 300 100 669 7.8 0 - - -
Δ9-THC-gluc Glucuronidated Δ9-THC 0.8 4 (5%) 4.4 ± 5.2 0.8 12.0 1.6 0 - - -
CBD Second most abundant cannabinoid 0.4 3 (4%) 0.5 ± 0.1 0.5 0.6 0.8 0 - - -
CBD-COOH Secondary metabolite of CBD 0.8 0 - - - 1.6 1 (1%) 1.9
CBD-gluc Glucuronidated CBD 0.8 0 - - - 0.8 9 (11%) 2.0 0.8 6.1
CBC Agonist of TRPA1 receptors 0.4 0 - - - 0.8 0 - - -
CBN Mildly psychotropic 0.8 0 - - - 1.6 0 - - -
CBG Antagonist of CB1 receptors 0.4 1 (1%) 0.2 - - 0.8 0 - - -
THCV Partial agonist of CB2 receptors 0.4 0 - - - 0.8 0 - - -
CBDV Homolog of CBD 0.4 0 - - - 0.8 0 - - -